BRK-B vs HDB
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
HDB exhibits a stable financial health profile with a Piotroski F-Score of 5/9, though it lacks an Altman Z-Score as is typical for banking institutions. The current price of $25.71 is almost perfectly aligned with its growth-based intrinsic value of $26.1, suggesting the stock has reached a fundamental floor after a severe correction. While the company maintains a strong track record of earnings surprises and a 'Strong Buy' analyst consensus, these are offset by negative YoY revenue growth and a completely bearish technical trend (0/100). The valuation is further complicated by an exceptionally high Price-to-Book ratio of 10.61, which is aggressive for the regional banking sector.
Compare Another Pair
Related Comparisons
BRK-B vs HDB: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and HDFC Bank Limited (HDB) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.